期刊
SCIENCE
卷 333, 期 6045, 页码 1030-1034出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1206954
关键词
-
资金
- NIH
- Paralyzed Veterans of America research foundation [2757]
CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, is expressed on antigen-presenting cells (APCs) and is essential for immune activation. Although agonistic CD40 antibodies have been developed for immunotherapy, their clinical efficacy has been limited. We have found that coengagement of the Fc domain of agonistic CD40 monoclonal antibodies (mAbs) with the inhibitory Fc gamma receptor Fc gamma RIIB is required for immune activation. Direct comparison of mAbs to CD40 enhanced for activating Fc gamma R binding, hence capable of cytotoxicity, or for inhibitory Fc gamma RIIB binding, revealed that enhancing Fc gamma RIIB binding conferred immunostimulatory activity and considerably greater anti-tumor responses. This unexpected requirement for Fc gamma RIIB in enhancing CD40-mediated immune activation has direct implications for the design of agonistic antibodies to TNFR as therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据